Wezel, F., Erben, P., Gaiser, T., Budjan, J., Hardenberg, J. v., & Michel, M. S. (2018). Complete and durable remission of human epidermal growth factor receptor 2-positive metastatic urothelial carcinoma following third-line treatment with trastuzumab and gemcitabine. Urologia internationalis, 100(1), . https://doi.org/10.1159/000443280
Chicago-Zitierstil (17. Ausg.)Wezel, Felix, Philipp Erben, Timo Gaiser, Johannes Budjan, Jost von Hardenberg, und Maurice Stephan Michel. "Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-positive Metastatic Urothelial Carcinoma Following Third-line Treatment with Trastuzumab and Gemcitabine." Urologia Internationalis 100, no. 1 (2018). https://doi.org/10.1159/000443280.
MLA-Zitierstil (9. Ausg.)Wezel, Felix, et al. "Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-positive Metastatic Urothelial Carcinoma Following Third-line Treatment with Trastuzumab and Gemcitabine." Urologia Internationalis, vol. 100, no. 1, 2018, https://doi.org/10.1159/000443280.